A2A Pharmaceuticals, Inc.

10% owner at BMEA

Sold, on record
$20.3M
Dollars the filings state
Form 4 sales
6
Latest Jun 1, 2023
Form 144 notices
3
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BMEABiomea Fusion, Inc.10% owner

Sales by reason

0
Routine
2
Plan not stated
2
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale BMEAPlan not stated
    Jul 21, 2022 2022

    Sold 34,658 shares at $11.21 ($389k)

    A2A Pharmaceuticals, Inc., 10% owner

    Sold 0.8% of holdings ($48.9M position)4.3M shares leftFiling

  2. 2 Form 144 notice BMEANotice
    Apr 20, 2023 +273 days

    Filed to sell 200,000 shares ($5.5M)

    A2A Pharmaceuticals, Inc., 10% Stockholder

    No 10b5-1 planFiling

  3. 3 Form 4 sale BMEANo plan
    Apr 20, 2023 same day

    Sold 200,000 shares at $29.12 ($5.8M)

    A2A Pharmaceuticals, Inc., 10% owner

    No 10b5-1 planSold 4.9% of holdings ($119M position)3.9M shares leftFollows a Form 144Filing

  4. 4 Form 144 notice BMEANotice
    Apr 27, 2023 +7 days

    Filed to sell 400,000 shares ($12M)

    A2A Pharmaceuticals, Inc., Stakeholder

    No 10b5-1 plan11.5x usual sizeFiling

  5. 5 Form 4 sale BMEAUnusual
    May 9, 2023 +12 days

    Sold 250,000 shares at $34.30 ($8.6M)

    A2A Pharmaceuticals, Inc., 10% owner

    No 10b5-1 planSold 6.4% of holdings ($134M position)3.6M shares left7.2x usual sizeFiling

  6. 6 Form 4 sale BMEANo plan
    May 12, 2023 +3 days

    Sold 25,000 shares at $33.84 ($846k)

    A2A Pharmaceuticals, Inc., 10% owner

    No 10b5-1 planSold 0.7% of holdings ($124M position)3.6M shares left0.2x usual sizeFiling

  7. 7 Form 144 notice BMEANotice
    May 19, 2023 +7 days

    Filed to sell 1.5M shares ($48.2M)

    A2A Pharmaceuticals, Inc., 10% Stockholder

    No 10b5-1 plan43.3x usual sizeFiling

  8. 8 Form 4 sale BMEAUnusual
    Jun 1, 2023 +13 days

    Sold 125,000 shares at $34.11 ($4.3M)

    A2A Pharmaceuticals, Inc., 10% owner

    No 10b5-1 planSold 3.4% of holdings ($124M position)3.5M shares left3.6x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by A2A Pharmaceuticals, Inc.
Source
Jun 1, 2023Jun 2, 2023BMEA10% ownerForm 4 sale125,000$4.3M3.4%UnusualSEC
May 19, 2023May 19, 2023BMEA10% StockholderForm 144 notice1.5M$48.2MNoticeSEC
May 12, 2023May 17, 2023BMEA10% ownerForm 4 sale25,000$846k0.7%No planSEC
May 9, 2023May 10, 2023BMEA10% ownerForm 4 sale250,000$8.6M6.4%UnusualSEC
Apr 27, 2023Apr 27, 2023BMEAStakeholderForm 144 notice400,000$12MNoticeSEC
Apr 20, 2023Apr 26, 2023BMEA10% ownerForm 4 sale200,000$5.8M4.9%No planSEC
Apr 20, 2023Apr 20, 2023BMEA10% StockholderForm 144 notice200,000$5.5MNoticeSEC
Jul 21, 2022Jul 25, 2022BMEA10% ownerForm 4 sale34,658$389k0.8%Plan not statedSEC
Jun 24, 2022Jun 28, 2022BMEA10% ownerForm 4 sale34,658$408k0.8%Plan not statedSEC